Chapter 6 Flashcards
NK T cells
recognize glycolipids displayed by MCH like molecule CD1
CD40
expressed on B cells
NK cells
express CD16 and CD56
CD16
on NK cells
FcR for IgG
Ab dependent cell mediated cytotoxcity (ADCC)
NKG2D
family which activates NK cells
CD94 family of lectins
inhibit NK cells
cytokines which stimulate NK cell proliferations
IL2, 15
cytokines which stimulate NK activation
IL12, also stimulated the release of IFN-y
Class I HLA
A,B,C
heterodimer of polymorphic alpha (heavy) chain and non-polymorphic beta 2-microglobulin chain
Alpha divided into 1,2,3
alpha 1 and 2 make polymorphic peptide binding cleft
display internal Ags like viruses
Class II HLA
P,Q,R
dimer of alpha and beta chains, both polymorphic
alpha 1 and beta 1 create polymorphic peptide binding cleft
present extracellular stuff that has been internalized and processed like bacteria
activated CD4 cells
secrete IL2 and express high affinity IL2Rs
IL2 acts as GF in autocrine loop
display CD40L which bind CD40 on B cells and Macrophages
TH1
secrete IFN-y
TH2
secrete IL4 -> B cells -> IgE plasma cells and IL 5 -> Eos
TH17
IL17- neutraphils and monocytes
class switching
induced by IFN-y and IL4
Type I hypersensativity reaction
aka immediate hypersensitivity TH2,IgE -> mast cells -> inflammation occurs w/in minutes allergies systemic or local
initial reaction in type I
vasodilation, vascular leakage, smooth m contraction, glandular secretions
late phase reaction in type I
begins in 2-24 hours, can last for days
infiltration of Eos, neturophils, basophils, monocytes, and CD4 cells -> tissue damage
IL3,5, GM-CSF all promote survival of eos
IL5 most potent stimulator of eos
secretagoges of mast cells
IgE, C5a, C3a, codeine, morphine, adenosine, mellitin, heat, cold, sunlight
leukotrienes
C4,D4- most potent vasoactive and spasmotic agents
B4-chemotactic for neutrophils, eos, and monocytes
extreme temperature or exercise hypersenativites
not mediated by TH2 or IgE
non-atopic allergy
Type II hypersensativity
aka Ab mediated
transfusion reactions, hemolytic disease of newborn, autoimmune hemolytic anemia, drug reactions (haptens)
type III hypersensativity
aka immune complex mediated
elicit inflammation at site of deposition
systemic immune complex disease
acute serum sickness
morphology of type III
acute necrotizing vasculitis
intense neutrophil infiltration
fibrinoid necrosis
type IV
aka T cell mediated
APC released IL12
induced CD4 to become TH1
What cytokines released from APC induces TH17
IL1,6,23 and TGF beta
CD8 mediated type IV
autoimmune following viral infections graft rejection tumor rejection kills with perforins and granzymes releases IFN-a tuberculin reaction, contact dermatitis
3 requirements of autoimmune disease
presence of immune reaction specific for a self Ag or self tissue
evidence that reaction is not secondary to tissue damage, but is primary pathology
absence of another well defined cause
AIRE
critical for negative selection to occur in thymus for central tolerance
Treg cells
express CD25
FOXp3 mutations
IPEX
PTPN-22
tyrosine phosphatase
rheumatoid arthritis and DMI
NOD2
chrons disease
cytoplasmic sensor of microbes
IL2R-CD25, and IL7R
MS
Epitope spreading
when cell injury releases previously immune privileged self Ags
SLE
woman 9-1
2-3x higher in black and hispanic
arises in early 20s-30s
ANAs in SLE
dsDNA
histones (drug induced)
non-histone proteins bound to RNA
Abs to nuclear agents
nuclear florescent- homogenous/diffuse
Abs to chromatin, histones, maybe DNA
nuclear florescent- rim/peripheral
Abs to DNA
nuclear florescent- speckled pattern
most common, least specific
DNA nuclear constituents
nuclear florescent- nuclear pattern
RNA Abs
Other Abs in SLE
smooth m, RBCs, platelets, lymphocytes
despite Abs to coagulants are in hypercoagulant state
genetics of SLE
HLA-DQ
deficiencies in C3,4 fail to remove ICs
deficiencies in C1q fail to phagocytosis apoptotic cells
drugs that induce SLE
hyralazine, procainamide, d-pencillamine, isoniazid
HLA-DR4
Abs to histone
mechanism of tissue injury in SLE
Type III
nuclei damaged cells exposed to ANAs -> LE bodies -> engulfed by phagocytes -> LE cells
morphology of SLE
fibrinoid necrosis
type I and II lupus nephritis
minimal mesangial and mesangial proliferative
10-25%
mesangial cells proliferate and IC deposition involving glomerular capillaries
type III lupus nephritis
focal proliferative glomerulonephritis 20-35% less then 50% glomeruli involved glomeruli have crescent formation fibrinoid necrosis proliferation of endothelium and mesangial cells infiltrating leukocytes, eos intercapillary thrombi deposits primarily subendothelial
type IV lupus nephritis
diffuse proliferative glomerulonephritis 35-60% entire glomerulus affected acutely injured and chronically scarred most severe definitely symptomatic deposits primarily subendothelial
type V lupus nephritis
membranous glomerulonephritis diffuse thickening of capillary walls 10-15% severe proteinuria may occur concurrently w/another class deposits primarily subepithelial
skin SLE
facial erythema in butterfly area
uticaria, maculopapular lesions, and ulcers
photosensitive
vasculitis w/fibrinoid necrosis
joints SLE
non-erosive synovitis w/little to no deformity
effusions common
CNS SLE
Abs against synaptic membrane proteins
non-inflammatory occlusion of small vessels due to intimal proliferation